This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Okawa, K. K. Search for Related Content PubMed PubMed Citation Articles by Okawa, K. K. Social Bookmarking                         What's this?

Dose Response Studies of Bevantolol in Hypertensive Patients

University of Utah, College of Medicine, Bountiful, Utah

This multicenter study, conducted to determine the antihypertensive efficacy of bevantolol at different fixed doses compared with placebo was carried out at four separate institutions using a common protocol. One hundred thirty-nine patients with mild to moderate essential hypertension were enrolled. At doses of 200 to 400 mg/day bevantolol was clearly effective in lowering diastolic blood pressure and in maintaining this effect over the eight weeks of this double-blind study. Twice a day dosing is indicated since efficacy was evident 12 hours post- dosing. Bevantolol was well tolerated.

Angiology, Vol. 37, No. 3, 233-238 (1986)
DOI: 10.1177/000331978603700315


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?